A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer

Clinical trial NCT00078260 · COMPLETED

Trial details

NCT number: NCT00078260
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2003-12-01
Primary completion: 2006-10-01
Enrollment: 589

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.